本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Stoke Therapeutics, Inc.

9.36
+0.31003.43%
盘后9.360.00000.00%19:38 EDT
成交量:119.73万
成交额:1,121.61万
市值:5.11亿
市盈率:-5.68
高:9.60
开:9.07
低:9.05
收:9.05
数据加载中...
2024/03/25

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/25

重要事件披露

Form 8-K - Current report
2024/03/25

重要事件披露

Form 8-K - Current report
2024/03/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/26

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/26

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/08

重要事件披露

Form 8-K - Current report
2024/01/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/15

重要事件披露

Form 8-K - Current report
2023/12/01

重要事件披露

Form 8-K - Current report
2023/11/18

SEC问询函

Form CORRESP - Correspondence
2023/11/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/07

重要事件披露

Form 8-K - Current report
2023/11/07

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/10/26

重要事件披露

Form 8-K - Current report
2023/09/21

重要事件披露

Form 8-K - Current report